Physician-scientists: vanishing?

Biomedical research needs practicing physicians -- understanding the issues that arise in the clinic is arguably one of the best ways to inform the work done in the lab. But recently, there is evidence to suggest the numbers of physician-scientists -- MDs who dedicate a significant amount of their time to medical research -- may be dwindling, argues researcher and hematologist linkurl:Andrew Schafer;http://www.med.cornell.edu/research/aischafer/biography.html of Weill Cornell Medical College and

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Biomedical research needs practicing physicians -- understanding the issues that arise in the clinic is arguably one of the best ways to inform the work done in the lab. But recently, there is evidence to suggest the numbers of physician-scientists -- MDs who dedicate a significant amount of their time to medical research -- may be dwindling, argues researcher and hematologist linkurl:Andrew Schafer;http://www.med.cornell.edu/research/aischafer/biography.html of Weill Cornell Medical College and New York-Presbyterian Hospital/Weill Cornell Medical Center.
Andrew Schafer
Image: Weill Cornell Medical College
Schafer expressed his concerns about this "disturbing" trend to The Scientist, described in a new book he edited, linkurl:The Vanishing Physician-Scientist?.;http://www.cornellpress.cornell.edu/cup_detail.taf?ti_id=5493 TS: We do not have statistics on the numbers of physician-scientists so what makes you think that their role in the biomedical research community may be changing? AS: There are several very disturbing trends that indicate that the career path of the physician-scientist really is in trouble. First, NIH grant applications have more than doubled in the past 15 years, but it turns out that virtually all of that doubling is attributable to PhD medical scientists. The number of pure MDs who are applying for NIH grants has been really flat for 20 or 30 years. [Additionally], physicians drop out of research careers relatively early. At every point in the early life cycle of NIH funding, physician-scientists are more likely than PhD biomedical scientists to leave the NIH grant applicant pool. [This] is, to me, the most disturbing of all because it indicates that it's not [just] that the so called pipeline of physician scientists hasn't been expanding, but that this pipeline is actually leaking very badly. TS: Why do you think there has been this shift? AS: I think there are several things at play. First of all, I think that there are diminishing numbers of successful and happy physician-scientist role models and mentors, which one always needs to sustain one's career. Secondly, if you're an MD [who's] started an academic career, there tend to be too many distractions that are competing with one's full emersion into research -- clinical responsibilities, increasing administrative responsibilities, teaching responsibilities, and all the other things that go along with the typical academic physician. And then probably the most important factor for the dropout is the increasing unpredictability of grant support. Now, with this roller coaster, boom-or-bust erratic cycling of NIH funding, physician-scientists are leaving the research arena because they do have other career options to make a living. TS: What are the consequences if we continue in this direction? AS: Physician-scientists [are] completely indispensible to the medical research enterprise because they bring to medical research the unique perspective of asking scientific questions based on their direct experience with patients. So I don't think our society can afford to lose physician-scientists. TS: So what is the future of physician-scientists? AS: The message I [and other authors] try to convey is [that it's] not as grim as this sounds. I don't think they are vanishing. What is vanishing is our current or our old concepts of what a physician-scientist should look like. In the old days, we had the so-called triple-threat physician-scientists, who could allegedly, on any given day, move between the laboratory and the clinic and the classroom. That, if it ever existed, is definitely disappearing, if it hasn't already disappeared. But in a different form, especially in the form of teams, I think the physician-scientist does have a very bright future.
**__Related stories:__***linkurl:Monetize your Science;http://www.the-scientist.com/2010/2/1/57/1/
[February 2010]*linkurl:UK to boost clinical trial participation;http://www.the-scientist.com/blog/display/54769/
[25th June 2008]*linkurl:Translational Disconnect;http://www.the-scientist.com/article/display/54321/
[March 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform